Back
Alimera Sciences Quote, Financials, Valuation and Earnings
Sponsored
ALIM
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Buy
61
ALIM
Alimera Sciences
Last Price:
5.54
Seasonality Move:
-13.1%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Alimera Sciences Price Quote
$5.54
Alimera Sciences Key Stats
Buy
61
Alimera Sciences (ALIM)
is a Buy
Day range:
$5.54 - $5.54
52-week range:
$2.61 - $5.65
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.68
P/B ratio:
7.77%
Volume:
0
Avg. volume:
1.2M
1-year change:
73.67%
Market cap:
$301.3M
Revenue:
$80.8M
EPS:
$-0.31
How Much Does Alimera Sciences Make?
-
How Much Are Alimera Sciences's Sales Annually?
ALIM Revenues are $80.8M -
How Much Profit Does Alimera Sciences's Make A Year?
ALIM net income is -$20.1M
Is Alimera Sciences Growing As A Company?
-
What Is Alimera Sciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.54% -
What Is Alimera Sciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Alimera Sciences Stock Price Performance
-
Did Alimera Sciences Stock Go Up Last Month?
Alimera Sciences share price went down by -0.72% last month -
Did ALIM's Share Price Rise Over The Last Year?
ALIM share price rose by 73.67% over the past 1 year
What Is Alimera Sciences 52-Week High & Low?
-
What Is Alimera Sciences’s 52-Week High Share Price?
Alimera Sciences has traded as high as $5.65 over the past 52 weeks -
What Is Alimera Sciences’s 52-Week Low Share Price?
Alimera Sciences has traded as low as $2.61 over the past 52 weeks
Alimera Sciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Alimera Sciences?
-
How Much Debt Does Alimera Sciences Have?
Total long term debt quarterly is $69.7M -
How Much Cash Does Alimera Sciences Have?
Cash and short term investments quarterly total is $10.8M -
What Is Alimera Sciences’s Book Value Per Share?
Book value per share is 0.74
Is Alimera Sciences Cash Flow Positive?
-
What Is ALIM Cash Flow From Operations?
Cash flow from operations (TTM) is -$5.6M -
What Is Alimera Sciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$2M -
What Is Alimera Sciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$221K
Alimera Sciences Return On Invested Capital
-
Is Management Doing A Good Job?
ALIM return on invested capital is -13.3% -
What Is Alimera Sciences Return On Assets?
ROA measures how assets are converting to revenues and is -9.6% -
What Is ALIM Return On Equity?
ROE is a measure of profitability and is -33.3%
Alimera Sciences Earnings Date & Stock Price
-
What Is Alimera Sciences's Stock Price Today?
A single share of ALIM can be purchased today for 5.54 -
What Is Alimera Sciences’s Stock Symbol?
Alimera Sciences trades on the nasdaq under the ticker symbol: ALIM -
When Is Alimera Sciences’s Next Earnings Date?
The next quarterly earnings date for Alimera Sciences is scheduled on October 25, 2024 -
When Is ALIM's next ex-dividend date?
Alimera Sciences's next ex-dividend date is September 20, 2024 -
How To Buy Alimera Sciences Stock?
You can buy Alimera Sciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Alimera Sciences Competitors
-
Who Are Alimera Sciences's Competitors?
Below is a list of companies who compete with Alimera Sciences or are related in some way:
Alimera Sciences Dividend Yield
-
What Is ALIM Dividend Yield?
Alimera Sciences’s dividend yield currently is 0% -
What Is Alimera Sciences’s Payout Ratio?
Alimera Sciences’s payout ratio is 0% -
When Did Alimera Sciences Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Alimera Sciences’s Dividend Per Share?
Alimera Sciences pays a dividend of $0.00 per share
Alimera Sciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -339.33% |
Revenue: | 53.95% | 4.93% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 5.67 |
Upside from Last Price: | 2.29% |